10x Genomics, Inc.
| Security | TXG / 10x Genomics, Inc. |
| Insider | Shehnaaz Suliman |
This page shows the track record and history of SULIMAN SHEHNAAZ
insider trades in 10x Genomics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Shehnaaz Suliman in TXG / 10x Genomics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Shehnaaz Suliman in TXG / 10x Genomics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-05 | 2025-06-03 | 4 | SULIMAN SHEHNAAZ | TXG | Class A Common Stock | D | 15,357 | 28,616 | ||||||
| 2024-06-13 | 2024-06-11 | 4 | SULIMAN SHEHNAAZ | TXG | Class A Common Stock | D | 8,649 | 13,259 | ||||||
| 2023-06-16 | 2023-06-14 | 4 | SULIMAN SHEHNAAZ | TXG | Class A Common Stock | D | 1,865 | 4,610 | ||||||
| 2022-06-17 | 2022-06-15 | 4 | SULIMAN SHEHNAAZ | TXG | Class A Common Stock | D | 2,120 | 2,745 | ||||||
| 2021-06-15 | 2021-06-11 | 4 | SULIMAN SHEHNAAZ | TXG | Stock Option (right to buy) | D | 193.51 | 1,563 | 1,563 | |||||
| 2021-06-15 | 2021-06-11 | 4 | SULIMAN SHEHNAAZ | TXG | Class A Common Stock | D | 625 | 625 | ||||||
| 2020-06-17 | 2020-06-15 | 4 | SULIMAN SHEHNAAZ | TXG | Stock Option (right to buy) | D | 88.42 | 4,432 | 4,432 | |||||
| 2019-09-16 | 2019-09-16 | 4 | SULIMAN SHEHNAAZ | TXG | Stock Option (right to buy) | D | 30.00 | 100,000 | 100,000 | |||||
| 2019-09-16 | 2019-09-16 | 4 | SULIMAN SHEHNAAZ | TXG | Stock Option (right to buy) | D | 30.00 | -100,000 | 0 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
